Cargando…

Impact of Type 2 Diabetes on Impaired Kidney Function in Sub-Saharan African Populations

BACKGROUND: Diabetes is a leading risk factor for impaired kidney function, an indicator of chronic kidney disease. The aim of this study was to examine the association between type 2 diabetes (T2D) and impaired kidney function among adults in sub-Saharan Africa (SSA). METHODS: Participants were enr...

Descripción completa

Detalles Bibliográficos
Autores principales: Adebamowo, Sally N., Adeyemo, Adebowale A., Tekola-Ayele, Fasil, Doumatey, Ayo P., Bentley, Amy R., Chen, Guanjie, Zhou, Jie, Shriner, Daniel, Fasanmade, Olufemi Adetola, Okafor, Godfrey, Eghan, Benjamin, Agyenim-Boateng, Kofi, Adeleye, Jokotade, Balogun, Williams, Amoah, Albert G., Owusu, Samuel, Acheampong, Joseph, Johnson, Thomas, Oli, Johnnie, Adebamowo, Clement A., Rotimi, Charles N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884893/
https://www.ncbi.nlm.nih.gov/pubmed/27303364
http://dx.doi.org/10.3389/fendo.2016.00050
_version_ 1782434430683447296
author Adebamowo, Sally N.
Adeyemo, Adebowale A.
Tekola-Ayele, Fasil
Doumatey, Ayo P.
Bentley, Amy R.
Chen, Guanjie
Zhou, Jie
Shriner, Daniel
Fasanmade, Olufemi Adetola
Okafor, Godfrey
Eghan, Benjamin
Agyenim-Boateng, Kofi
Adeleye, Jokotade
Balogun, Williams
Amoah, Albert G.
Owusu, Samuel
Acheampong, Joseph
Johnson, Thomas
Oli, Johnnie
Adebamowo, Clement A.
Rotimi, Charles N.
author_facet Adebamowo, Sally N.
Adeyemo, Adebowale A.
Tekola-Ayele, Fasil
Doumatey, Ayo P.
Bentley, Amy R.
Chen, Guanjie
Zhou, Jie
Shriner, Daniel
Fasanmade, Olufemi Adetola
Okafor, Godfrey
Eghan, Benjamin
Agyenim-Boateng, Kofi
Adeleye, Jokotade
Balogun, Williams
Amoah, Albert G.
Owusu, Samuel
Acheampong, Joseph
Johnson, Thomas
Oli, Johnnie
Adebamowo, Clement A.
Rotimi, Charles N.
author_sort Adebamowo, Sally N.
collection PubMed
description BACKGROUND: Diabetes is a leading risk factor for impaired kidney function, an indicator of chronic kidney disease. The aim of this study was to examine the association between type 2 diabetes (T2D) and impaired kidney function among adults in sub-Saharan Africa (SSA). METHODS: Participants were enrolled from Ghana, Kenya, and Nigeria. Impaired kidney function was based on an estimated glomerular filtration rate <60 ml/min/1.73 m(2). Using logistic regression models, we conducted case–control analyses to estimate the multivariate-adjusted association of T2D and kidney function. RESULTS: We used data from 4815 participants for whom the mean (SD) age was 48 (15) years, 41% were male and 46% had T2D. Those with T2D were more likely to have impaired kidney function [13.4% (95% CI: 11.9–14.7)] compared to those without T2D [4.8% (95% CI: 4.0–5.6)], p-value <0.001. The multivariate odds ratio of impaired kidney function among those with type 2 diabetes was 1.50 (95% CI: 1.17–1.91) p-value = 0.001, compared to those without T2D. Also, individuals with T2D who were at least 60 years old, obese, hypertensive or dyslipidemic were more likely to have impaired kidney function compared to those without T2D. CONCLUSION: T2D was associated with 50% increased risk of impaired kidney function in this sample of adults from SSA. Interventions targeted at prevention, early diagnosis, and management of T2D are likely to reduce the burden of kidney disease in SSA.
format Online
Article
Text
id pubmed-4884893
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-48848932016-06-14 Impact of Type 2 Diabetes on Impaired Kidney Function in Sub-Saharan African Populations Adebamowo, Sally N. Adeyemo, Adebowale A. Tekola-Ayele, Fasil Doumatey, Ayo P. Bentley, Amy R. Chen, Guanjie Zhou, Jie Shriner, Daniel Fasanmade, Olufemi Adetola Okafor, Godfrey Eghan, Benjamin Agyenim-Boateng, Kofi Adeleye, Jokotade Balogun, Williams Amoah, Albert G. Owusu, Samuel Acheampong, Joseph Johnson, Thomas Oli, Johnnie Adebamowo, Clement A. Rotimi, Charles N. Front Endocrinol (Lausanne) Endocrinology BACKGROUND: Diabetes is a leading risk factor for impaired kidney function, an indicator of chronic kidney disease. The aim of this study was to examine the association between type 2 diabetes (T2D) and impaired kidney function among adults in sub-Saharan Africa (SSA). METHODS: Participants were enrolled from Ghana, Kenya, and Nigeria. Impaired kidney function was based on an estimated glomerular filtration rate <60 ml/min/1.73 m(2). Using logistic regression models, we conducted case–control analyses to estimate the multivariate-adjusted association of T2D and kidney function. RESULTS: We used data from 4815 participants for whom the mean (SD) age was 48 (15) years, 41% were male and 46% had T2D. Those with T2D were more likely to have impaired kidney function [13.4% (95% CI: 11.9–14.7)] compared to those without T2D [4.8% (95% CI: 4.0–5.6)], p-value <0.001. The multivariate odds ratio of impaired kidney function among those with type 2 diabetes was 1.50 (95% CI: 1.17–1.91) p-value = 0.001, compared to those without T2D. Also, individuals with T2D who were at least 60 years old, obese, hypertensive or dyslipidemic were more likely to have impaired kidney function compared to those without T2D. CONCLUSION: T2D was associated with 50% increased risk of impaired kidney function in this sample of adults from SSA. Interventions targeted at prevention, early diagnosis, and management of T2D are likely to reduce the burden of kidney disease in SSA. Frontiers Media S.A. 2016-05-30 /pmc/articles/PMC4884893/ /pubmed/27303364 http://dx.doi.org/10.3389/fendo.2016.00050 Text en Copyright © 2016 Adebamowo, Adeyemo, Tekola-Ayele, Doumatey, Bentley, Chen, Zhou, Shriner, Fasanmade, Okafor, Eghan, Agyenim-Boateng, Adeleye, Balogun, Amoah, Owusu, Acheampong, Johnson, Oli, Adebamowo and Rotimi. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Adebamowo, Sally N.
Adeyemo, Adebowale A.
Tekola-Ayele, Fasil
Doumatey, Ayo P.
Bentley, Amy R.
Chen, Guanjie
Zhou, Jie
Shriner, Daniel
Fasanmade, Olufemi Adetola
Okafor, Godfrey
Eghan, Benjamin
Agyenim-Boateng, Kofi
Adeleye, Jokotade
Balogun, Williams
Amoah, Albert G.
Owusu, Samuel
Acheampong, Joseph
Johnson, Thomas
Oli, Johnnie
Adebamowo, Clement A.
Rotimi, Charles N.
Impact of Type 2 Diabetes on Impaired Kidney Function in Sub-Saharan African Populations
title Impact of Type 2 Diabetes on Impaired Kidney Function in Sub-Saharan African Populations
title_full Impact of Type 2 Diabetes on Impaired Kidney Function in Sub-Saharan African Populations
title_fullStr Impact of Type 2 Diabetes on Impaired Kidney Function in Sub-Saharan African Populations
title_full_unstemmed Impact of Type 2 Diabetes on Impaired Kidney Function in Sub-Saharan African Populations
title_short Impact of Type 2 Diabetes on Impaired Kidney Function in Sub-Saharan African Populations
title_sort impact of type 2 diabetes on impaired kidney function in sub-saharan african populations
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884893/
https://www.ncbi.nlm.nih.gov/pubmed/27303364
http://dx.doi.org/10.3389/fendo.2016.00050
work_keys_str_mv AT adebamowosallyn impactoftype2diabetesonimpairedkidneyfunctioninsubsaharanafricanpopulations
AT adeyemoadebowalea impactoftype2diabetesonimpairedkidneyfunctioninsubsaharanafricanpopulations
AT tekolaayelefasil impactoftype2diabetesonimpairedkidneyfunctioninsubsaharanafricanpopulations
AT doumateyayop impactoftype2diabetesonimpairedkidneyfunctioninsubsaharanafricanpopulations
AT bentleyamyr impactoftype2diabetesonimpairedkidneyfunctioninsubsaharanafricanpopulations
AT chenguanjie impactoftype2diabetesonimpairedkidneyfunctioninsubsaharanafricanpopulations
AT zhoujie impactoftype2diabetesonimpairedkidneyfunctioninsubsaharanafricanpopulations
AT shrinerdaniel impactoftype2diabetesonimpairedkidneyfunctioninsubsaharanafricanpopulations
AT fasanmadeolufemiadetola impactoftype2diabetesonimpairedkidneyfunctioninsubsaharanafricanpopulations
AT okaforgodfrey impactoftype2diabetesonimpairedkidneyfunctioninsubsaharanafricanpopulations
AT eghanbenjamin impactoftype2diabetesonimpairedkidneyfunctioninsubsaharanafricanpopulations
AT agyenimboatengkofi impactoftype2diabetesonimpairedkidneyfunctioninsubsaharanafricanpopulations
AT adeleyejokotade impactoftype2diabetesonimpairedkidneyfunctioninsubsaharanafricanpopulations
AT balogunwilliams impactoftype2diabetesonimpairedkidneyfunctioninsubsaharanafricanpopulations
AT amoahalbertg impactoftype2diabetesonimpairedkidneyfunctioninsubsaharanafricanpopulations
AT owususamuel impactoftype2diabetesonimpairedkidneyfunctioninsubsaharanafricanpopulations
AT acheampongjoseph impactoftype2diabetesonimpairedkidneyfunctioninsubsaharanafricanpopulations
AT johnsonthomas impactoftype2diabetesonimpairedkidneyfunctioninsubsaharanafricanpopulations
AT olijohnnie impactoftype2diabetesonimpairedkidneyfunctioninsubsaharanafricanpopulations
AT adebamowoclementa impactoftype2diabetesonimpairedkidneyfunctioninsubsaharanafricanpopulations
AT rotimicharlesn impactoftype2diabetesonimpairedkidneyfunctioninsubsaharanafricanpopulations